Site icon Healthcare, Lifestyle, Entertainment, Living and Travel

Ascendis gets FDA orphan drug status for Yorvipath for hypothyroidism



Ascendis gets FDA orphan drug status for Yorvipath for hypothyroidism



Source: Seekingalpha

Exit mobile version